Burning Rock Biotech (BNR) Receivables - Net (2020 - 2025)
Historic Receivables - Net for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to $25.8 million.
- Burning Rock Biotech's Receivables - Net rose 884.72% to $25.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.8 million, marking a year-over-year increase of 884.72%. This contributed to the annual value of $27.1 million for FY2024, which is 5172.38% up from last year.
- According to the latest figures from Q3 2025, Burning Rock Biotech's Receivables - Net is $25.8 million, which was up 884.72% from $26.5 million recorded in Q2 2025.
- Burning Rock Biotech's Receivables - Net's 5-year high stood at $27.1 million during Q4 2024, with a 5-year trough of -$2.2 million in Q2 2022.
- In the last 5 years, Burning Rock Biotech's Receivables - Net had a median value of $18.3 million in 2023 and averaged $17.8 million.
- As far as peak fluctuations go, Burning Rock Biotech's Receivables - Net tumbled by 11778.9% in 2022, and later soared by 101802.14% in 2023.
- Burning Rock Biotech's Receivables - Net (Quarter) stood at $14.5 million in 2021, then rose by 10.19% to $15.9 million in 2022, then grew by 12.08% to $17.9 million in 2023, then soared by 51.72% to $27.1 million in 2024, then fell by 4.74% to $25.8 million in 2025.
- Its last three reported values are $25.8 million in Q3 2025, $26.5 million for Q2 2025, and $22.0 million during Q1 2025.